LegisTrack
Back to all bills
HR 3501119th CongressIn Committee

To amend title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventive physical examination.

Introduced: May 19, 2025
Healthcare
Standard Summary
Comprehensive overview in 1-2 paragraphs

This bill would amend the Medicare provisions (Title XVIII) to require cognitive impairment detection during two preventive healthcare visits: the Medicare annual wellness visit (AWV) and the initial preventive physical examination (IPPE). For the AWV, the bill would replace the current requirement with a mandate that the detection be performed using cognitive impairment tools identified by the National Institute on Aging (NIA) as meeting its criteria for use in primary care, and that the tool used and the results be documented in the patient’s medical record. For the IPPE, the bill adds the detection of cognitive impairment to the items that must be addressed in the patient agreement. The changes would apply to AWVs and IPPEs furnished on or after January 1, 2026. The measure emphasizes early diagnosis to improve care planning, access to treatments, and support services, and it highlights the substantial and growing burden of Alzheimer’s disease and other dementias.

Key Points

  • 1Replaces the AWV requirement with a mandate to use an NIA-identified cognitive impairment detection tool applicable to primary care, and to document the tool and results in the patient’s medical record.
  • 2Applies to AWVs furnished on or after January 1, 2026.
  • 3For the IPPE, requires that, in addition to the existing agreement, the detection of cognitive impairment (as described in the AWV provision) be included in the IPPE process, effective for IPPEs furnished on or after January 1, 2026.
  • 4Tools must meet the National Institute on Aging’s criteria for detecting cognitive impairment in primary care settings.
  • 5Documentation of the tool used and the results must be included in the patient’s medical record.

Impact Areas

Primary group/area affected: Medicare beneficiaries aged 65 and older who receive AWVs or IPPEs, and the primary care clinicians who perform these visits.Secondary group/area affected: The Medicare program (CMS) and healthcare systems that administer AWVs and IPPEs, including potential workflow and training needs for providers.Additional impacts: Potential for earlier detection and care planning for Alzheimer’s disease and related dementias; possible effects on caregiver burden, long-term care planning, and overall healthcare costs; considerations related to disparities in dementia prevalence and detection across racial/ethnic groups (as highlighted in the bill’s findings).
Generated by gpt-5-nano on Oct 7, 2025